Quarterly report [Sections 13 or 15(d)]

Investment in account receivable (Tables)

v3.25.1
Investment in account receivable (Tables)
 3 Months Ended
Mar. 31, 2025
Receivables [Abstract]  
Schedule of receivables with imputed interest

The investment in account receivable consists of the following at March 31, 2025 and December 31, 2024:

  

    March 31,
2025		     December 31,
2024		  
Face value*   $ 287,200     $ 287,200  
Impairment     (250,208 )     (250,208 )
Total     36,992       36,992  
Unamortized discount     (36,992 )     (36,992 )
Net balance     -       -  
Long term portion   $ -     $ -  

 

* Coincident with the June 11, 2024 impairment, accounts receivable of $2,300 were reclassed and concurrently impaired. Prior to the full impairment, the Company reduced the face value of its investment in account receivable by an additional $100 per month for five receivable payment installments.